Jason Dussault - Goodbody Health Co IR

Insider

Jason Dussault is Co IR of Goodbody Health
Age 49
Webhttps://www.goodbodyhealth.com

Goodbody Health Management Efficiency

The company has return on total asset (ROA) of (0.1333) % which means that it has lost $0.1333 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5554) %, meaning that it generated substantial loss on money invested by shareholders. Goodbody Health's management efficiency ratios could be used to measure how well Goodbody Health manages its routine affairs as well as how well it operates its assets and liabilities.
Goodbody Health has accumulated 249.82 K in total debt with debt to equity ratio (D/E) of 0.04, which may suggest the company is not taking enough advantage from borrowing. Goodbody Health has a current ratio of 2.47, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Goodbody Health until it has trouble settling it off, either with new capital or with free cash flow. So, Goodbody Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Goodbody Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Goodbody to invest in growth at high rates of return. When we think about Goodbody Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Zohar KrivorotCannara Biotech
46
Mba BEconAvicanna
N/A
Friederike RotschMERCK Kommanditgesellschaft auf
51
Peter GuenterMerck KGaA ADR
61
Brian ShermanCannara Biotech
N/A
David AbitbolCannara Biotech
N/A
Carlos MueteAvicanna
N/A
Julia BouvetCannara Biotech
N/A
Gerhard SchmitzMerck KGaA ADR
60
Alexander WolfeCannara Biotech
N/A
Peter GuenterMERCK Kommanditgesellschaft auf
61
Belen MDMerck KGaA ADR
63
Matthias HeinzelMERCK Kommanditgesellschaft auf
56
Etienne LedouxCannara Biotech
N/A
Dirk ToepferMerck KGaA ADR
N/A
France LandryCannara Biotech
N/A
Barbara WeilandMerck KGaA ADR
49
Caitlin JohnstonAvicanna
N/A
Roland AlvarezAvicanna
N/A
Barbara WeilandMERCK Kommanditgesellschaft auf
49
Dirk ToepferMERCK Kommanditgesellschaft auf
N/A
Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom. The company was formerly known as Sativa Wellness Group Inc. and changed its name to Goodbody Health Inc. in January 2022. Goodbody Health is traded on OTC Exchange in the United States. Goodbody Health [GDBYF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Goodbody Health Leadership Team

Elected by the shareholders, the Goodbody Health's board of directors comprises two types of representatives: Goodbody Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Goodbody. The board's role is to monitor Goodbody Health's management team and ensure that shareholders' interests are well served. Goodbody Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Goodbody Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
FCCA ACIS, Company CFO
Emily Critchley, Group HR
George Thomas, Chief Director
Krzysztof Wojtanowski, Head Poland
Marc Howells, CEO Director
Julia Edwards, Group Marketing
Jason Dussault, Co IR

Goodbody Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Goodbody Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Goodbody OTC Stock

Goodbody Health financial ratios help investors to determine whether Goodbody OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goodbody with respect to the benefits of owning Goodbody Health security.